Evidence map›Paper›PMID 32877538›Full record

ArticleThe Journal of infectious diseases2020

Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States.

Heather Bradley, Elizabeth M Rosenthal, Meredith A Barranco, Tomoko Udo, Patrick S Sullivan, Eli S Rosenberg

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Estimating the population size of people who inject drugs in Canada, 2021.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Estimated Number of People Who Inject Drugs in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heather BradleyGeorgia State University School of Public Health, Atlanta, Georgia, USA.
Elizabeth M RosenthalUniversity at Albany School of Public Health, State University of New York, Albany, New York, USA.
Meredith A BarrancoUniversity at Albany School of Public Health, State University of New York, Albany, New York, USA.
Tomoko UdoUniversity at Albany School of Public Health, State University of New York, Albany, New York, USA.
Patrick S SullivanEmory University Rollins School of Public Health, Atlanta, Georgia, USA.
Eli S RosenbergUniversity at Albany School of Public Health, State University of New York, Albany, New York, USA.

Funding

Increasing representation of black communities in SARS-CoV-2 serosurveys by understanding barriers and motivations for participationR01DA051302 · NIDA · GEORGIA STATE UNIVERSITY · PI BRADLEY, HEATHER, ROSENBERG, ELI SAMUEL · 2020 to 2024
$4.3M
NIDA NIH HHS R01 DA051302
6 · The paper itself

Abstract

backgroundIn the United States, injection is an increasingly common route of administration for opioids and other substances. Estimates of the number of persons who inject drugs (PWID) are needed for monitoring risk-specific infectious disease rates and health services coverage.

methodsWe reviewed design and instruments for 4 national household surveys, 2012-2016, for their ability to produce unbiased injection drug use (IDU) prevalence estimates. We explored potential analytic adjustments for reducing biases through use of external data on (1) arrest, (2) narcotic overdose mortality, and (3) biomarker-based sensitivity of self-reported illicit drug use.

resultsEstimated national past 12 months IDU prevalence ranged from 0.24% to 0.59% across surveys. All surveys excluded unstably housed and incarcerated persons, and estimates were based on <60 respondents reporting IDU behavior in 3 surveys. No surveys asked participants about nonmedical injection of prescription drugs. Analytic adjustments did not appreciably change IDU prevalence estimates due to suboptimal specificity of data points.

conclusionsPWID population size estimates in the United States are based on small numbers and are likely biased by undercoverage of key populations and self-report. Novel methods as discussed in this article may improve our understanding of PWID population size and their health needs.

Indexed as

Epidemiological MonitoringAdolescentAdultDemographyDrug OverdoseDrug UsersFemaleHumansLaw EnforcementMaleMiddle AgedPrevalenceRisk AssessmentSelf ReportSubstance Abuse, IntravenousUnited Statesinjection behaviorpopulation-based surveysPWID

Identifiers

PMID32877538
PMCPMC8176905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.